Jupiter Life Line Hospitals
Jupiter Life Line Hospitals Performance
Day Range
- Low 1,108.00
- High 1,221.00
52 Week Range
- Low 970.00
- High 1,221.00
- Open Price1,120.80
- Previous Close1,105.45
- Volume118704
Start SIP in Jupiter Life Line Hospitals
Start SIPJupiter Life Line Hospitals Investment Rating
-
Master Rating:
-
Jupiter Life Line Hospitals Ltd has an operating revenue of Rs. 949.26 Cr. on a trailing 12-month basis. An annual revenue growth of 50% is outstanding, Pre-tax margin of 11% is healthy, ROE of 17% is exceptional. The company has a high debt to equity of 159%, which can be a reason to worry. The stock from a technical standpoint is comfortably placed above its key moving averages, around 7% and 7% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around -3% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 55 which is a POOR score indicating inconsistency in earnings, a RS Rating of 31 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 72 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Jun 2022 |
---|---|---|---|---|
Oper Rev Qtr Cr | 227 | 208 | 210 | 179 |
Operating Expenses Qtr Cr | 168 | 157 | 158 | 130 |
Operating Profit Qtr Cr | 59 | 51 | 52 | 49 |
Depreciation Qtr Cr | 8 | 8 | 7 | 7 |
Interest Qtr Cr | 9 | 8 | 7 | 7 |
Tax Qtr Cr | 12 | 10 | 15 | 0 |
Net Profit Qtr Cr | 36 | 30 | 27 | 37 |
Jupiter Life Line Hospitals Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 11
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹1,072.07
- 50 Day
- ₹1,060.86
- 100 Day
- ₹
- 200 Day
- ₹
- 20 Day
- ₹1,055.75
- 50 Day
- ₹1,052.53
- 100 Day
- ₹
- 200 Day
- ₹
Jupiter Life Line Hospitals Resistance and Support
Resistance | |
---|---|
First Resistance | 1,197.87 |
Second Resistance | 1,265.93 |
Third Resistance | 1,310.87 |
RSI | 68.81 |
MFI | 86.76 |
MACD Single Line | 12.41 |
MACD | 21.65 |
Support | |
---|---|
First Resistance | 1,084.87 |
Second Resistance | 1,039.93 |
Third Resistance | 971.87 |
Jupiter Life Line Hospitals Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 122,962 | 5,011,931 | 40.76 |
Week | 50,922 | 2,722,810 | 53.47 |
1 Month | 65,521 | 3,266,898 | 49.86 |
6 Month | 182,235 | 8,623,381 | 47.32 |
Jupiter Life Line Hospitals Result Highlights
Jupiter Life Line Hospitals Synopsis
NSE-Medical-Hospitals
Jupiter Life Line Ho is involved in the business activities of Hospital activities. Company’s Total Operating Revenue is Rs. 657.28 Cr. and Equity Capital is Rs. 50.87 Cr. for the Year ended 31/03/2022. Jupiter Life Line Hospitals Ltd. is a Public Limited Listed company incorporated on 18/11/2002 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is U85100MH2002PLC137908 and registration number is 137908.Market Cap | 7,408 |
Sales | 645 |
Shares in Float | 3.87 |
No of funds | 55 |
Yield |
Book Value | 17.57 |
U/D Vol ratio | 1.1 |
LTDebt / Equity | 91 |
Alpha | 0.02 |
Beta | 0.78 |
Jupiter Life Line Hospitals
Owner Name | Sep-23 |
---|---|
Promoters | 40.91% |
Mutual Funds | 11.57% |
Insurance Companies | 0.76% |
Foreign Portfolio Investors | 4.62% |
Financial Institutions/ Banks | 0.06% |
Individual Investors | 29.91% |
Others | 12.17% |
Jupiter Life Line Hospitals Management
Name | Designation |
---|---|
Dr. Ajay Thakker | Chairman & Managing Director |
Dr. Ankit Thakker | Executive Director & CEO |
Dr. Bhaskar Shah | Non Executive Director |
Mr. Vadapatra Raghavan | Non Executive Director |
Dr. Darshan Vora | Independent Director |
Dr.(Ms.) Jasmin Patel | Independent Director |
Ms. Urmi Popat | Independent Director |
Mr. Satish Utekar | Independent Director |
Jupiter Life Line Hospitals Forecast
Price Estimates
Jupiter Life Line Hospitals Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-11-10 | Quarterly Results | |
2023-10-06 | Quarterly Results |
Jupiter Life Line Hospitals FAQs
What is Share Price of Jupiter Life Line Hospitals ?
Jupiter Life Line Hospitals share price is ₹1,129 As on 10 December, 2023 | 05:01
What is the Market Cap of Jupiter Life Line Hospitals ?
The Market Cap of Jupiter Life Line Hospitals is ₹7407.6 Cr As on 10 December, 2023 | 05:01
What is the P/E ratio of Jupiter Life Line Hospitals ?
The P/E ratio of Jupiter Life Line Hospitals is As on 10 December, 2023 | 05:01
What is the PB ratio of Jupiter Life Line Hospitals ?
The PB ratio of Jupiter Life Line Hospitals is 20.4 As on 10 December, 2023 | 05:01